Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Use of next generation sequencing and quantitative mass spectrometry to determine HER2 status
    Meeting Abstract

    Razavi, P.; Cecchi, F.; Ross, D. S.; Middha, S.; Zehir, A.; Arcila, M. E.; Hembrough, T. A.; Berger, M. F.; Scaltriti, M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Cancer susceptibility mutations in individuals with breast and ovarian cancer using next-generation sequencing
    Meeting Abstract

    Offit, K.; Schrader, K. A.; Maxwell, K. N.; Vijai, J.; Hart, S.; Thomas, T.; Wubbenhorst, B.; Ravichandran, V.; Moore, R.; Hu, C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Correlation of PIK3CA mutations in cell-ree DNA (cfDNA) and efficacy of everolimus (EVE in metastatic breast cancer: Results from BOLERO-2
    Meeting Abstract

    Moynahan, M. E.; Sung, P.; Chen, D.; He, W.; Samoila, A.; You, D.; Bhatt, T.; Patel, P.; Ringeisen, F. P.; Hortobagyi, G. N.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1b/2 study of intratumoral Ad-RTS-hIL-12 + veledimex in patients with chemotherapy-responsive locally advanced or metastatic breast cancer
    Meeting Abstract

    McArthur, H. L.; Page, D. B.; Proverbs-Singh, T. A.; Solomon, S. B.; Hudis, C. A.; Norton, L.; Patil, S.; Barrett, J. A.; Lebel, F. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study
    Meeting Abstract

    Lacouture, M. E.; Konner, J. A.; Stevens, J.; Brouwer, S.; Narain, N. R.; Ye, R.; Ravipaty, S.; Sarangarajan, R.; Akmaev, V. R.; Jimenez, J. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A prospective analysis of surgery and survival in stage IV breast cancer (TBCRC 013)
    Meeting Abstract

    King, T. A.; Lyman, J.; Gonen, M.; Reyes, S.; Hwang, E. S. S.; Rugo, H. S.; Liu, M. C.; Boughey, J. C.; Jacobs, L. K.; McGuire, K. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I evaluation of the PI3 kinase (PI3K) inhibitor taselisib (GDC-0032) in multiple locally advanced or metastatic PIK3CA mutant solid tumor types
    Meeting Abstract

    Jhaveri, K. L.; Bedard, P. L.; Cejalvo, J. M.; Hart, L. L.; Juric, D.; Kelly, K.; Lockhart, A. C.; Melnyk, A.; Moore, K. N.; Nemunaitis, J. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A genome-wide association study (GWAS) of progression-free survival (PFS) in metastatic breast cancer (MBC) patients treated with letrozole (L) with or without bevacizumab (B) in CALGB 40503
    Meeting Abstract

    Innocenti, F.; Owzar, K.; Jiang, C.; Sibley, A.; Mulkey, F.; Carey, L. A.; Tripathy, D.; Schneider, B. P.; Barry, W. T.; Winer, E. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)+ metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Proverbs-Singh, T. A.; Corben, A.; Moynahan, M. E.; Patil, S.; Boyle, L. A.; Hudis, C. A.; Traina, T. A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): A retrospective multicenter analysis
    Meeting Abstract

    Goff, L. W.; Lowery, M. A.; Jordan, E.; Wang, R.; Bocobo, A. G.; Chou, J. F.; O'Reilly, E. M.; Harding, J. J.; Kemeny, N. E.; Capanu, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save